These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37864309)

  • 21. Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.
    Hakki M; Lewis JS
    Infection; 2018 Jun; 46(3):431-434. PubMed ID: 29460229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
    Satlin MJ; Jenkins SG; Walsh TJ
    Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
    Satlin MJ; van Duin D; Tamma PD; Lodise TP; Van Tyne D; Rodvold KA; Rouphael N; Evans SR; Fowler VG; Hamasaki T; Patel R; Komarow L; Baum K; Souli M; Schwager N; Bonomo RA; Doi Y;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S305-S313. PubMed ID: 37843118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Resistance in Organ Transplant Recipients.
    Giannella M; Rinaldi M; Viale P
    Infect Dis Clin North Am; 2023 Sep; 37(3):515-537. PubMed ID: 37244806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
    Larcher R; Laffont-Lozes P; Roger C; Doncesco R; Groul-Viaud C; Martin A; Loubet P; Lavigne JP; Pantel A; Sotto A
    Front Cell Infect Microbiol; 2022; 12():1048633. PubMed ID: 36544909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
    Bow EJ
    Curr Opin Infect Dis; 2011 Dec; 24(6):545-53. PubMed ID: 22001945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2022 Aug; 75(2):187-212. PubMed ID: 35439291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
    Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
    Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections.
    Kanj SS; Bassetti M; Kiratisin P; Rodrigues C; Villegas MV; Yu Y; van Duin D
    Int J Antimicrob Agents; 2022 Sep; 60(3):106633. PubMed ID: 35787918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
    Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation.
    Pilmis B; Weiss E; Scemla A; Le Monnier A; Grossi PA; Slavin MA; Van Delden C; Lortholary O; Paugam-Burtz C; Zahar JR
    Clin Microbiol Infect; 2023 Jan; 29(1):38-43. PubMed ID: 35716912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of microbial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: a cross-sectional study from Palestine.
    Arman G; Zeyad M; Qindah B; Abu Taha A; Amer R; Abutaha S; Koni AA; Zyoud SH
    BMC Infect Dis; 2022 Feb; 22(1):146. PubMed ID: 35144553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients.
    Pouch SM
    Curr Opin Organ Transplant; 2021 Aug; 26(4):424-431. PubMed ID: 34148979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
    Satlin MJ; Calfee DP; Chen L; Fauntleroy KA; Wilson SJ; Jenkins SG; Feldman EJ; Roboz GJ; Shore TB; Helfgott DC; Soave R; Kreiswirth BN; Walsh TJ
    Leuk Lymphoma; 2013 Apr; 54(4):799-806. PubMed ID: 22916826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Angeles Cuesta M; Chinea A; Español-Morales I; Fernandez-Abellán P; Gudiol C; González-Sierra P; Rojas R; Sánchez-Pina JM; Vadillo IS; Sánchez M; Varela R; Vázquez L; Guerreiro M; Monzo P; Lopera C; Aiello TF; Peyrony O; Soriano A; Garcia-Vidal C
    Microbiol Spectr; 2023 Aug; 11(4):e0067423. PubMed ID: 37367629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.